Joseph E. Payne, Director at Vallon Pharmaceuticals, Inc. (VLON), bought 17,500 shares at $3.85 ($72K) on 2021-05-25, disclosed to the SEC on 2021-05-27.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.85 | 10,700 | $41K | 57.4% |
| 2 | $4.50 | 6,800 | $31K | 42.6% |
| Total | $4.10 avg | 17,500 | $72K | 100% |
| Filing → |
| ARCT | BUY | 2019-08-30 | $56K | — | Filing → |